发明名称 3,4-DI-SUBSTITUTED CYCLOBUTENE-1, 2-DIONES AS CXC CHEMOKINE RECEPTOR ANTAGONISTS
摘要 There are disclosed compounds of formula (I) wherein the variables A and B a re an aryl or heteroaryl group as defined in the claims, or a prodrug thereof, or a pharmaceutically acceptable salt, solvate or isomer of said compound or of said prodrug, which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.</SDOAB >
申请公布号 CA2436351(A1) 申请公布日期 2002.10.03
申请号 CA20022436351 申请日期 2002.02.01
申请人 SCHERING CORPORATION;PHARMACOPEIA, INC. 发明人 LI, GE;DWYER, MICHAEL;MERRITT, J. ROBERT;FERREIRA, JOHAN A.;NELSON, KINGSLEY H., JR.;ROKOSZ, LAURA L.;PACHTER, JONATHAN;BALDWIN, JOHN J.;KAISER, BERND;BOND, RICHARD W.;CHAO, JIANPING;AKI, CYNTHIA J.;TAVERAS, ARTHUR G.
分类号 A61K31/136;A61K31/166;A61K31/167;A61K31/18;A61K31/192;A61K31/198;A61K31/216;A61K31/24;A61K31/27;A61K31/277;A61K31/36;A61K31/397;A61K31/40;A61K31/4174;A61K31/4184;A61K31/4192;A61K31/426;A61K31/433;A61K31/4402;A61K31/4406;A61K31/445;A61K31/4453;A61K31/495;A61K31/505;A61K31/5375;A61P1/00;A61P7/00;A61P7/02;A61P9/10;A61P11/00;A61P11/06;A61P13/12;A61P17/00;A61P17/06;A61P19/02;A61P25/08;A61P25/28;A61P29/00;A61P31/04;A61P33/06;A61P37/02;A61P37/08;A61P43/00;C07C221/00;C07C225/20;C07C229/42;C07C229/64;C07C237/36;C07C237/44;C07C255/58;C07C255/59;C07C271/20;C07C311/08;C07C311/21;C07D205/04;C07D207/08;C07D207/16;C07D211/60;C07D213/74;C07D213/89;C07D231/38;C07D231/44;C07D233/64;C07D235/06;C07D239/42;C07D249/18;C07D277/20;C07D277/24;C07D277/28;C07D277/42;C07D277/56;C07D285/08;C07D295/12;C07D295/13;C07D295/135;C07D295/16;C07D295/192;C07D295/20;C07D295/205;C07D317/66;C07D333/38;C07D403/12;C07D405/12;(IPC1-7):C07C225/20;C07D521/00 主分类号 A61K31/136
代理机构 代理人
主权项
地址